Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction

安慰剂 勃起功能障碍 医学 人参 安慰剂组 内科学 勃起功能 显著性差异 替代医学 病理
作者
Enrico Andrade,Alexandre Amato de Mesquita,Joaquim de Almeida Claro,P. M. Andrade,Valdemar Ortiz,Mário Paranhos,Miguel Srougi,Tibet Erdogrun
出处
期刊:Asian Journal of Andrology [Medknow]
卷期号:9 (2): 241-244 被引量:139
标识
DOI:10.1111/j.1745-7262.2007.00210.x
摘要

To examine the treatment efficacy of Korean Red Ginseng (KRG) in impotent men with erectile dysfunction (ED).A total of 60 patients presenting mild or mild to moderate ED were enrolled in a double-blind, placebo-controlled study in which the efficacies of KRG and a placebo were compared. The patients received either 1,000 mg (3 times daily) of KRG or a placebo.The five-item version of the International Index of Erectile Function (IIEF-5) score after the treatment was significantly higher in the KRG group compared with that before the treatment (from 16.4 +/- 2.9 to 21.0 +/- 6.3, P < 0.0001). In contrast, there was no difference before and after the treatment in the placebo group (from 17.0 +/- 3.1 to 17.7 +/- 5.6, P > 0.05). In the KRG group, 20 patients (66.6%), reported improved erection, significant in the global efficacy question (P < 0.01); in the placebo group there was no significance. Scores on questions 2 (rigidity), 3 (penetration), 4 and 5 (maintenance), were significantly higher for KRG than those for the placebo when those questions were answered after 12 weeks of each treatment (P < 0.01). When the score in the KRG group was compared to the placebo group after the treatment, there was a significant improvement in total score (IIEF-5 score) in questions 3 and 5 for the KRG-treated group (P < 0.001 and P < 0.0001, respectively). The levels of serum testosterone, prolactine and cholesterol after the treatment were not statistically significant different between the KRG and the placebo group (P > 0.05).Our data show that KRG can be an effective alternative to the invasive approaches for treating male ED.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
勤恳的德地完成签到,获得积分10
1秒前
HY完成签到,获得积分10
1秒前
1秒前
anny2022完成签到,获得积分10
2秒前
LGZ完成签到 ,获得积分10
2秒前
Qing完成签到 ,获得积分10
3秒前
hebhm完成签到,获得积分10
3秒前
上官若男应助科研通管家采纳,获得10
3秒前
Jasper应助科研通管家采纳,获得10
4秒前
laber应助科研通管家采纳,获得30
4秒前
英姑应助科研通管家采纳,获得10
4秒前
cdercder应助科研通管家采纳,获得10
4秒前
cdercder应助科研通管家采纳,获得10
4秒前
4秒前
七龙珠完成签到,获得积分10
4秒前
独特的凝云完成签到 ,获得积分10
5秒前
高木同学发布了新的文献求助10
5秒前
平常的毛豆应助zzl1111采纳,获得10
6秒前
manmanzhong完成签到 ,获得积分10
6秒前
伶俐碧萱完成签到 ,获得积分10
6秒前
外套waitlen发布了新的文献求助10
7秒前
简单的思菱完成签到 ,获得积分10
8秒前
xxj完成签到 ,获得积分10
9秒前
我瞎蒙完成签到,获得积分10
9秒前
10秒前
喜悦的板凳完成签到 ,获得积分10
11秒前
张小度ever完成签到 ,获得积分10
11秒前
12秒前
钟sss完成签到 ,获得积分10
12秒前
踏实采波完成签到,获得积分10
14秒前
14秒前
kaka发布了新的文献求助10
14秒前
gaga发布了新的文献求助10
16秒前
zzl1111完成签到,获得积分10
16秒前
外套waitlen完成签到,获得积分20
16秒前
mrjohn完成签到,获得积分10
17秒前
钟sss关注了科研通微信公众号
18秒前
yueyueyue完成签到,获得积分10
18秒前
沟通亿心完成签到,获得积分10
18秒前
叶雨思空完成签到 ,获得积分10
20秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3815941
求助须知:如何正确求助?哪些是违规求助? 3359417
关于积分的说明 10402560
捐赠科研通 3077261
什么是DOI,文献DOI怎么找? 1690255
邀请新用户注册赠送积分活动 813693
科研通“疑难数据库(出版商)”最低求助积分说明 767743